- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Bortezomib (VELCADE)
Total 957 results
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMantle Cell LymphomaChina, Belgium, Thailand, United States, Spain, Canada, Colombia, Italy, Morocco, Brazil, Turkey, Chile, Malaysia, Israel, Portugal, Singapore, Russian Federation, Philippines, Tunisia, Austria, Czechia, Germany, Hungary, India, Poland, R... and more
-
University of UlmCentre Hospitalier de Lens (Co-Sponsor)CompletedWaldenström's MacroglobulinemiaGermany
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.Completed
-
University of LouisvilleJames Graham Brown Cancer CenterWithdrawn
-
European Myeloma NetworkFondazione EMN Italy OnlusCompleted
-
Peter MacCallum Cancer Centre, AustraliaJanssen-Cilag Ltd.CompletedMultiple MyelomaAustralia
-
National Cancer Institute (NCI)CompletedStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Henan Cancer HospitalRecruitingMarginal Zone LymphomaChina
-
Samsung Medical CenterActive, not recruitingMultiple MyelomaKorea, Republic of
-
University of Wisconsin, MadisonMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterWithdrawn
-
University of CincinnatiCompleted
-
University of ArkansasJanssen, LPActive, not recruitingMultiple MyelomaUnited States
-
University of ArkansasActive, not recruitingUARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionMultiple MyelomaUnited States
-
Washington University School of MedicineTerminatedMultiple MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)UnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Sherif Farag, MB, BSHoosier Cancer Research Network; Cephalon, Inc.TerminatedBendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple MyelomaMultiple MyelomaUnited States
-
NovartisCompletedMultiple MyelomaCanada, United States, Australia, Taiwan, Ireland
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Teva takedaActive, not recruitingMultiple MyelomaUnited States, Spain, Belgium, Israel
-
Boehringer IngelheimCompletedOvarian Neoplasms | Peritoneal NeoplasmsSpain
-
Iran Hepatitis NetworkBaqiyatallah Research Center for Gastroenterology and Liver DiseasesUnknown
-
First Affiliated Hospital of Zhejiang UniversityNot yet recruitingAdvanced Biliary Tract CarcinomaChina
-
PharmaMarCompletedMultiple MyelomaSpain, France
-
University of CologneJohnson & Johnson Pharmaceutical Research & Development, L.L.C.; German Hodgkin...Terminated
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaAustralia, Japan, Spain, Germany, Poland, Belgium, Israel, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, China, Brazil, Czechia, United States, Netherlands, United Kingdom, Greece, France
-
Peking Union Medical College HospitalXian-Janssen Pharmaceutical Ltd.Active, not recruitingAmyloidosis; SystemicChina
-
Children's Mercy Hospital Kansas CityMillennium Pharmaceuticals, Inc.TerminatedAcute Lymphoblastic Leukemia | Lymphoblastic LymphomaUnited States
-
PharmaMarTerminated
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLCCompleted
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
Eli Lilly and CompanyCompletedMultiple MyelomaMexico, United States, Germany, Italy, France, Poland, Taiwan, Spain, Turkey, United Kingdom, Korea, Republic of, Greece, Canada, Brazil, Netherlands
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingMultiple Myeloma | Newly Diagnosed | MRD | High Risk
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
Alison WalkerNovartis; Millennium Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid... and other conditionsUnited States
-
Peking Union Medical College HospitalRecruitingIdiopathic Multicentric Castleman's DiseaseChina
-
OncotherapeuticsCelgene CorporationTerminatedMultiple MyelomaUnited States
-
Imperial College LondonAstraZeneca; Cancer Research UKCompleted
-
Chonnam National University HospitalUnknownMultiple MyelomaKorea, Republic of
-
Milton S. Hershey Medical CenterMayo ClinicCompleted
-
Sheba Medical CenterUnknown
-
PETHEMA FoundationRecruitingRefractory Multiple MyelomaSpain
-
AbbVieActive, not recruitingMultiple MyelomaUnited States, France, Germany, Italy, Japan, Spain
-
Singapore General HospitalJanssen, LP; International Myeloma FoundationActive, not recruitingMultiple Myeloma | MyelomaSingapore
-
Dayanand Medical College and HospitalCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma and other conditionsUnited States
-
The First Affiliated Hospital of Soochow UniversityUnknown
-
Array Biopharma, now a wholly owned subsidiary...CompletedMultiple Myeloma, Plasma Cell LeukemiaUnited States
-
University Hospital Plymouth NHS TrustCompleted